Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

50.55
Delayed Data
As of Oct 20
 -0.13 / -0.26%
Today’s Change
30.89
Today|||52-Week Range
50.95
+40.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
AssetsCash2.2B2.7B2.4B3.3B
 
 
 
 
 
Short Term Investment Cash196.7M652.0M-332.9M507.0M
 
 
 
 
 
Cash & Short Term Investments2.6B3.0B2.6B3.5B
 
 
 
 
 
 
ReceivablesReceivables2.6B3.4B3.2B2.8B
 
 
 
 
 
 
InventoriesInventories2.2B2.0B2.2B2.3B
 
 
 
 
 
 
Current AssetsOther Current Assets412.6M0.000.00434.1M
 
 
 
Current Assets7.8B8.5B8.0B9.0B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross--8.2B----
 
 
Depreciation---3.9B----
 
 
Intangible Assets430.0M385.0M398.6M406.0M
 
 
 
 
 
Other Assets430.0M385.0M398.6M406.0M
 
 
 
 
 
Total Assets13.2B13.8B13.6B15.0B
 
 
 
 
 
 
LiabilitiesAccounts Payable673.4M852.7M544.0M653.0M
 
 
 
 
 
Short Term Debt68.8M32.5M88.2M258.2M
 
 
 
 
 
Accrued Expenses--986.3M----
 
 
Other Current Liabilities4.7B4.6B5.8B5.2B
 
 
 
 
 
Other Liabilities6.3B6.7B7.0B6.7B
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-404.6M-378.7M-380.4M-267.7M
 
 
 
 
 
Other Liabilities0.000.000.000.00
 
 
Total Liabilities6.9B7.4B7.8B7.6B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity6.2B6.4B5.8B7.4B
 
 
 
 
 
Total Shareholder Equity6.2B6.4B5.8B7.4B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.0B2.0B2.0B2.0B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.